(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 53.96%214M | -57.58%249M | 186.21%25M | -92.59%12M | -69.58%73M | -35.05%139M | -63.47%587M | -104.60%-29M | -72.35%162M | -23.08%240M |
Net income from continuing operations | 672.73%63M | -85.06%149M | -208.70%-25M | -56.96%68M | -78.88%117M | -104.20%-11M | -38.04%997M | -95.52%23M | -74.27%158M | 52.62%554M |
Operating gains losses | -36.36%7M | 114.40%35M | 500.00%12M | 800.00%7M | 102.07%5M | 650.00%11M | -3,571.43%-243M | 101.85%2M | -103.70%-1M | -388.10%-242M |
Depreciation and amortization | 3.13%33M | 37.78%124M | 23.08%32M | 29.17%31M | 38.10%29M | 68.42%32M | 30.43%90M | 36.84%26M | 41.18%24M | 23.53%21M |
Asset impairment expenditure | --0 | -20.00%4M | --0 | --3M | --0 | -75.00%1M | 400.00%5M | --1M | --0 | --0 |
Deferred tax | --0 | -57.61%39M | -67.74%10M | -25.93%20M | -44.83%16M | -240.00%-7M | 216.46%92M | 234.78%31M | 345.45%27M | 390.00%29M |
Other non cashItems | 0.00%6M | -21.62%29M | -66.67%2M | -25.00%6M | 50.00%15M | -53.85%6M | -71.97%37M | --6M | --8M | --10M |
Change In working capital | -1.87%105M | 66.50%-131M | 94.92%-6M | -127.78%-123M | 17.42%-109M | 222.99%107M | -196.21%-391M | -220.41%-118M | 12.90%-54M | -62.96%-132M |
-Change in receivables | 43.66%-40M | -112.83%-34M | -91.76%7M | -35.92%66M | ---36M | -192.21%-71M | 214.72%265M | -28.57%85M | 150.00%103M | --0 |
-Change in inventory | -7.89%175M | 75.00%-43M | 91.01%-8M | 16.67%-110M | -82.54%-115M | 69.64%190M | -59.26%-172M | 31.54%-89M | -97.01%-132M | -53.66%-63M |
-Change in prepaid assets | 200.00%12M | 158.06%18M | 95.65%-1M | -116.67%-13M | 1,033.33%28M | 300.00%4M | -240.91%-31M | -675.00%-23M | 0.00%-6M | -125.00%-3M |
-Change in payables and accrued expense | -153.85%-33M | 114.85%45M | 86.00%-14M | 85.71%-2M | -13.95%74M | 95.27%-13M | -207.45%-303M | -199.01%-100M | -106.57%-14M | 207.14%86M |
-Change in other current liabilities | -200.00%-9M | -3.57%27M | 58.82%27M | -175.00%-6M | 80.00%9M | -50.00%-3M | 142.42%28M | 54.55%17M | 900.00%8M | 183.33%5M |
-Change in other working capital | ---- | 19.10%-144M | -112.50%-17M | -346.15%-58M | ---- | ---- | -474.19%-178M | -14.29%-8M | -360.00%-13M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 53.96%214M | -57.58%249M | 186.21%25M | -92.59%12M | -69.58%73M | -35.05%139M | -63.47%587M | -104.60%-29M | -72.35%162M | -23.08%240M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 13.04%-40M | -229.87%-200M | -1.72%-59M | -32.43%-49M | -115.08%-46M | 17.86%-46M | 162.10%154M | 18.31%-58M | 50.67%-37M | 529.58%305M |
Capital expenditure reported | 16.67%-40M | -0.51%-196M | 3.39%-57M | -23.08%-48M | 4.44%-43M | 7.69%-48M | 17.37%-195M | 3.28%-59M | 46.58%-39M | 40.00%-45M |
Net PPE purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | --353M | --0 | --0 | ---- |
Net intangibles purchas and sale | ---1M | ---5M | ---1M | ---2M | ---2M | --0 | --0 | --0 | --0 | ---- |
Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | ---15M | --0 | --0 | --0 |
Dividends received (cash flow from investment activities) | --0 | --2M | --0 | --0 | --0 | --2M | --0 | --0 | --0 | --0 |
Net other investing changes | --1M | -109.09%-1M | ---- | ---- | ---- | ---- | 191.67%11M | 110.00%1M | --2M | ---3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 13.04%-40M | -229.87%-200M | -1.72%-59M | -32.43%-49M | -115.08%-46M | 17.86%-46M | 162.10%154M | 18.31%-58M | 50.67%-37M | 529.58%305M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -91.40%-178M | 77.30%-210M | 67.81%-159M | 133.33%88M | -132.62%-46M | 69.81%-93M | -98.50%-925M | -2,644.44%-494M | 24.14%-264M | 443.90%141M |
Net issuance payments of debt | 0.00%-9M | -125.18%-35M | -28.57%-9M | -14.29%-8M | -105.63%-9M | -28.57%-9M | 447.50%139M | -75.00%-7M | -133.33%-7M | 300.00%160M |
Net common stock issuance | ---6M | --0 | --0 | --0 | --0 | --0 | -96.24%-783M | ---288M | 25.81%-296M | ---6M |
Cash dividends paid | -21.74%-28M | -2.79%-258M | 0.00%-189M | -21.05%-23M | -9.52%-23M | -4.55%-23M | -348.21%-251M | -721.74%-189M | -26.67%-19M | -133.33%-21M |
Net other financing activities | -121.31%-135M | 376.67%83M | 490.00%39M | 105.17%119M | -275.00%-14M | 29.07%-61M | -203.45%-30M | -211.11%-10M | -15.94%58M | -83.33%8M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -91.40%-178M | 77.30%-210M | 67.81%-159M | 133.33%88M | -132.62%-46M | 69.81%-93M | -98.50%-925M | -2,644.44%-494M | 24.14%-264M | 443.90%141M |
Net cash flow | ||||||||||
Beginning cash position | -20.27%645M | -15.29%809M | -39.71%841M | -47.84%784M | 1.63%809M | -15.29%809M | 1,518.64%955M | 240.24%1.4B | 508.50%1.5B | 1,593.62%796M |
Current changes in cash | ---4M | 12.50%-161M | 66.78%-193M | 136.69%51M | ---- | ---- | -120.60%-184M | -207.20%-581M | -185.28%-139M | 243.00%686M |
Effect of exchange rate changes | --4M | -107.89%-3M | 40.00%-3M | -80.65%6M | -128.57%-6M | --0 | 1,166.67%38M | -266.67%-5M | --31M | --21M |
End cash Position | -20.27%645M | -20.27%645M | -20.27%645M | -39.71%841M | -47.84%784M | 1.63%809M | -15.29%809M | -15.29%809M | 240.24%1.4B | 508.50%1.5B |
Free cash from | 90.11%173M | -87.76%48M | 62.50%-33M | -130.89%-38M | -85.64%28M | -43.83%91M | -71.41%392M | -115.44%-88M | -76.02%123M | -17.72%195M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.